Status:
UNKNOWN
Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Antithrombotic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Develop an exemplary anti-thrombotic therapy network data platform and a intelligent terminal application(APP), establish an new pattern used in long-time anti-thrombotic management based on dynamic r...
Detailed Description
1.1.Develop and optimize antithrombotic therapy network data platform and thrombotic risk evaluate the intelligent terminal APP, establish a new pattern based on dynamic risk evaluation and event-trig...
Eligibility Criteria
Inclusion
- age≥18 years;
- clinical confirmed coronary heart disease. Including definite history of myocardial infarction, stable angina with exercise electrocardiography test(treadmill exercise) positive, unstable angina with electrocardiogram(ECG) ischemic changes or troponin positive, coronary angiography(CAG) hints at least one coronary artery stenoses over 50%, post-operative of percutaneous coronary intervention(PCI) or coronary artery bypass grafting(CABG);
- Be receiving anti-thrombotic therapy;
- Be voluntary to participate in the study., and sign informed consent form.
Exclusion
- inability to obtain consent from participants;
- unable to record the medical data through terminal applications(APP)
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2020
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03454854
Start Date
November 1 2017
End Date
December 20 2020
Last Update
May 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong General Hospital
Guangzhou, Guangdong, China